scholarly journals An Effective Case of Combined Arterial and Portal Infusion Chemotherapy for Sigmoid Colon Cancer with Multiple Liver Metastases.

1994 ◽  
Vol 27 (5) ◽  
pp. 1090-1093
Author(s):  
Yoshikazu Suzuki ◽  
Shigehiko Yagi ◽  
Keiichi Shinozaki ◽  
Kazuhide Iwakawa ◽  
Kenzi Inoue ◽  
...  
2017 ◽  
Vol 66 (2) ◽  
pp. 129-134
Author(s):  
Hidefumi KUBO ◽  
Yuta KIMURA ◽  
Toru KAWAOKA ◽  
Makoto MIYAHARA ◽  
Ryouichi SHIMIZU ◽  
...  

2014 ◽  
Vol 99 (6) ◽  
pp. 795-801 ◽  
Author(s):  
Yuji Toiyama ◽  
Yasuhiro Inoue ◽  
Takahito Kitajima ◽  
Masato Okigami ◽  
Mikio Kawamura ◽  
...  

Abstract A 39-year-old man received a diagnosis of unresectable multiple liver metastases from multiple colorectal cancers with familial adenomatous polyposis. After construction of an ileostomy, modified FOLFOX6 (mFOLFOX6) with panitumumab was administrated because rectal cancer and sigmoid colon cancer are KRAS wild type. The 13 courses of chemotherapy resulted in a marked reduction in the size of liver metastases and sigmoid colon cancer. Consequently, curative resection with total colectomy, ileal pouch anal anastomosis, and liver metastasis resection with radiofrequency ablation was performed. Progression of KRAS wild-type rectal cancer after chemotherapy suggested that each clone from rectal and sigmoid colon cancer might have a different sensitivity to epidermal growth factor receptor antibody. Immunohistochemical analysis revealed loss of PTEN expression in rectal cancer compared with liver metastases from sigmoid colon cancer, showing that the difference of mFOLFOX6 with panitumumab might be related to activation of the PI3K-AKT pathway.


2018 ◽  
Vol 71 (1) ◽  
pp. 37-40
Author(s):  
Sunao Ito ◽  
Nobuhiro Haruki ◽  
Hideki Tsuji ◽  
Koshiro Harata

1995 ◽  
Vol 38 (5) ◽  
pp. 550-552 ◽  
Author(s):  
Yutaka J. Kawamura ◽  
Hideaki Saito ◽  
Toshio Sawada ◽  
Tetsuichiro Muto ◽  
Hideo Nagai

2016 ◽  
Vol 10 (1) ◽  
pp. 204-211 ◽  
Author(s):  
Nobuhiro Morinaga ◽  
Naritaka Tanaka ◽  
Yoshinori Shitara ◽  
Masatoshi Ishizaki ◽  
Takatomo Yoshida ◽  
...  

Brain metastasis from colorectal cancer is infrequent and carries a poor prognosis. Herein, we present a patient alive 10 years after the identification of a first brain metastasis from sigmoid colon cancer. A 39-year-old woman underwent sigmoidectomy for sigmoid colon cancer during an emergency operation for pelvic peritonitis. The pathological finding was moderately differentiated adenocarcinoma. Eleven months after the sigmoidectomy, a metastatic lesion was identified in the left ovary. Despite local radiotherapy followed by chemotherapy, the left ovarian lesion grew, so resection of the uterus and bilateral ovaries was performed. Adjuvant chemotherapy with tegafur-uracil (UFT)/calcium folinate (leucovorin, LV) was initiated. Seven months after resection of the ovarian lesion, brain metastases appeared in the bilateral frontal lobes and were treated with stereotactic Gamma Knife radiosurgery. Cervical and mediastinal lymph node metastases were also diagnosed, and irradiation of these lesions was performed. After radiotherapy, 10 courses of oxaliplatin and infused fluorouracil plus leucovorin (FOLFOX) were administered. During FOLFOX administration, recurrent left frontal lobe brain metastasis was diagnosed and treated with stereotactic Gamma Knife radiosurgery. In this case, the brain metastases were well treated with stereotactic Gamma Knife radiosurgery, and the systemic disease arising from sigmoid colon cancer has been kept under control with chemotherapies, surgical resection, and radiotherapy.


2016 ◽  
Vol 14 (1) ◽  
Author(s):  
Keiichi Arakawa ◽  
Soichiro Ishihara ◽  
Kazushige Kawai ◽  
Junichi Shibata ◽  
Kensuke Otani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document